Medicus Pharma Ltd Ordinary Shares MDCX 深 滬
等待開盤 08-19 09:30:00 美东时间
2.0591
+0.099
+5.06%
華盛通- 最 高2.39
- 今 開2.10
- 成交量 60.19万股
- 最 低 2.01
- 昨 收 1.96
- 總市值 3260.11万
- 52周最高 8.94
- 市盈率 靜 --
- 換手率 3.80%
- 52周最低 1.80
- 委 比 77.48%
- 總股本 1583.27万
- 歷史最高 8.94
- 量 比 2.97
- 振 幅 19.39%
- 歷史最低 1.80
- 每 手 1
- 風險率 1.06%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多D. Boral Capital Maintains Buy on Medicus Pharma, Maintains $27 Price Target
D. Boral Capital analyst Jason Kolbert maintains Medicus Pharma (NASDAQ:MDCX) with a Buy and maintains $27 price target.
08-05 19:48
Medicus Pharma and HelixNano Announce Vaccine Collaboration
An announcement from Medicus Pharma Ltd ( ($MDCX) ) is now available. On August...
08-04 19:59
Medicus and HelixNano Team Up to Develop Needle-Free, Thermostable mRNA Vaccines
Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus") and Helix Nanotechnologies Inc. ("HelixNano"), a Boston-based biotech company focused on developing an advanced mRNA platform to create vaccines and therapies to augment the
08-04 19:39
Medicus Pharma Appoints Deloitte for Licensing Deal
Medicus Pharma Ltd ( ($MDCX) ) has shared an update. On July 29, 2025, Medicus ...
07-30 19:19
Medicus Pharma Enters Warrant Inducement Agreement
Medicus Pharma Ltd ( ($MDCX) ) just unveiled an announcement. On July 14, 2025,...
07-14 21:18
美股大行评级 | 潜在涨幅83.3%！Robinhood获Keybanc升目标价至110美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1147088025548091392.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Leerink Partners：维持再鼎医药(ZLAB)"跑赢大市"评级，目标价从73美元升至75美元</p> <p>• 美银证券：维持BioCryst Pharma(BCRX)"买入"评级，目标价从13美元升至15美元
07-02 09:54
Medicus Pharma To Acquire Antev In All-Stock Deal, Issuing 2.67M Shares Plus Up To $65M In Milestone Payments Tied To FDA Approvals
On June 29, 2025, Medicus Pharma Ltd. ("Medicus" or the "Company"), Antev Limited ("Antev") and certain securityholders of Antev entered into a definitive securities exchange agreement (the "Definitive Agreement"),
07-01 01:54
Medicus Pharma to acquire Antev
Medicus Pharma (NASDAQ:MDCX) said on Monday that it has entered into a definitive agreement to acquire all the issued and outstanding shares of Antev on a share exchange basis. Medicus will acquire a...
06-30 19:54
Medicus Pharma Ltd. Expands Leadership and Advances Clinical Trials
Medicus Pharma Ltd ( ($MDCX) ) has shared an announcement. Medicus Pharma Ltd. ...
06-24 00:58
Medicus Pharma Secures $4.5M Through Debenture Issuance
Medicus Pharma Ltd ( ($MDCX) ) has provided an announcement. Medicus Pharma Ltd...
06-21 04:58
